Test Your Skills: Diagnosis and Treatment Challenges in a Cardiopulmonary Patient

Released On
July 31, 2020

Expires On
July 31, 2021

Media Type

Completion Time
45 minutes

Cardiology, Family/GP, Int. Med, Primary Care, Pulmonology, Resp. Therapy


Scroll to the Bottom of this Information to Begin this Course

Sponsored by The Academy for Continued Healthcare Learning (ACHL) and the Purdue University College of Pharmacy.


This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc.

Credit Available

  • Physicians — maximum of .75 AMA PRA Category 1 Credit(s)

All other health care professionals completing this course will be issued a statement of participation.

Target Audience

This activity is intended for pulmonologists, cardiopulmonologists, cardiologists, and other HCPs managing patients with PAH.

Program Overview

In this case-based activity, Dr. Harrison Farber takes learners through the differential diagnosis and treatment of two cardiopulmonary patients. Discussion topics include differential diagnostic procedures, guideline recommendations, and therapy selection. Clinical decision points throughout the activity allow learners to test their skills in managing cardiopulmonary patients. Through patient case scenarios and the latest clinical data, this activity provides practical guidance to improve early detection, classify/stratify patients, and select effective therapy.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss the impact of emerging data and guidelines on differential diagnostic procedures for the cardiopulmonary patient.
  • Formulate comprehensive management plans for a cardiopulmonary patient that encompass pharmacologic and supportive care approaches based on current guideline recommendations.
  • Interpret the efficacy and safety data of novel and emerging pharmacotherapies including combination therapy to effectively treat a cardiopulmonary patient.


Harrison W. Farber, MD

Division of Pulmonary, Critical Care, and Sleep Medicine
Tufts Medical Center
Boston, MA

Accreditation Statement

Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Credit Designation

Purdue University College of Pharmacy designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosures of Conflicts of Interest

Purdue University College of Pharmacy requires that the faculty participating in a CME activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME activity.

The following financial relationships have been provided:

Harrison W. Farber, MD

  • Safety Advisory Board: Acceleron, Altavant, Actelion Pharmaceuticals, United Therapeutics
  • Speakers Bureau: Bayer HealthCare Pharmaceuticals

All additional planning committee members, ACHL, and Purdue University College of Pharmacy staff have no relationships to disclose.

Instructions for Participation and Credit

This activity will take approximately 45 minutes to complete. To receive credit, participants are required to complete the pretest, view the online activity and complete the posttest and evaluation. To receive credit, 80% must be achieved on the posttest. A certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Laurie Novoryta at Lnovoryta@achlcme.org.

Hardware and Software Requirements

  1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.
  2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
  3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher
  4. Adobe Flash Player 12.0 (or higher).
  5. Adobe Reader to print certificate.
  6. Allow ActiveX controls to run on your computer: If the yellow strip appears on the top of your web browser while running the Webcast, right click on it and select Allow blocked contents to run.
  7. Turn the Pop-up blocker off: On the Tools menu, point to Pop-up Blocker, and then click Turn Off Pop-up Blocker.

Disclosure of Unlabeled Use

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None


The content for this activity was developed independently of the commercial supporter. All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the grantor.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications and/or devices that may exceed their FDA-approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. Purdue University College of Pharmacy requires the speaker to disclose that a product is not labeled for the use under discussion.